Gaithersburg Pharmaceutical Preparation 65 W Watkins Mill Rd GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs and vaccines. Each of our product candidates uses patent-protected technology to deliver genes that produce beneficial proteins. GenVec�s lead product, TNFerade�, is currently in a pivotal, Phase III clinical study (PACT) in locally advanced pancreatic cancer. TNFerade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head and neck cancer. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and HSV-2. Gaithersburg MD Pharmaceutical Preparation Genvec Inc www.genvec.com GenVec GNVC biotech biopharm vaccines HIV AIDS cancer oncology PACT Study Phase III clinical trial pancreatic cancer locally advanced pancreatic cancer vision loss wet age macular degeneration NASDAQ hearing loss foot and mouth influenza rec GenVec GNVC biotech biopharm vaccines HIV AIDS cancer oncology PACT Study Phase III clinical trial pancreatic cancer locally advanced pancreatic cancer vision loss wet age macular degeneration NASDAQ hearing loss foot and mouth influenza rec Business Reviews Genvec Inc Testimonials